AbbVie

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. 

CEO
Robert A. Michael
CEORobert A. Michael
Employees
55,000
Employees55,000
Headquarters
North Chicago, Illinois
HeadquartersNorth Chicago, Illinois
Founded
2011
Founded2011
Employees
55,000
Employees55,000

ABBV Key Statistics

Market cap
390.02B
Market cap390.02B
Price-Earnings ratio
105.08
Price-Earnings ratio105.08
Dividend yield
2.93%
Dividend yield2.93%
Average volume
4.79M
Average volume4.79M
High today
High today
Low today
Low today
Open price
$217.30
Open price$217.30
Volume
0.00
Volume0.00
52 Week high
$221.77
52 Week high$221.77
52 Week low
$163.81
52 Week low$163.81

ABBV News

Simply Wall St 27m
Synopsys And 2 Other Stocks That May Offer Value For Investors

As the Federal Reserve's recent interest rate cut creates a mixed reaction in U.S. stock markets, with the Dow Jones Industrial Average rising while the Nasdaq...

Synopsys And 2 Other Stocks That May Offer Value For Investors
TipRanks 19h
AbbVie’s Phase 3 Pediatric Constipation Study Completes, Potential Market Impact Looms

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powe...

Seeking Alpha 23h
Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial

Healthcare On the Move Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial Sep. 17, 2025 8:46 AM ET Oruka Therapeutics, Inc. (ORKA) Stoc...

Oruka jumps as lead drug outperforms AbbVie’s Skyrizi in early-stage trial

Analyst ratings

65%

of 31 ratings
Buy
64.5%
Hold
32.3%
Sell
3.2%

More ABBV News

Benzinga 24h
This Workday Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

This Workday Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Wednesday
TipRanks 1d
AbbVie’s Strategic Positioning and Growth Prospects Highlight Compelling Investment Opportunity

AbbVie, the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Luisa Hector from Berenberg Bank upgraded the rating on the sto...

Simply Wall St 5d
Assessing AbbVie Valuation After Rinvoq Exclusivity Extension Secures Key Revenue Driver

If you are trying to figure out what to do with your AbbVie (ABBV) shares, the most recent development might catch your eye. The company just settled with gener...

Assessing AbbVie Valuation After Rinvoq Exclusivity Extension Secures Key Revenue Driver
TipRanks 7d
AbbVie’s ABBV-1088 Study: A Closer Look at Recent Developments

Abbvie ((ABBV)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock po...

TipRanks 7d
‘Really Long Runway’: AbbVie Stock Jumps afer Settlement on Anti-Inflammatory Drug

The shares of AbbVie (ABBV) climbed nearly 5% on Thursday morning after the American drugmaker reached a settlement with manufacturers producing “generic” or ch...

TipRanks 7d
AbbVie Settles to Delay RINVOQ Generics Until 2037

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to...

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.